Division of Cancer Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Cancer Sci. 2012 Apr;103(4):632-7. doi: 10.1111/j.1349-7006.2012.02219.x. Epub 2012 Mar 8.
Cell growth demands new protein synthesis, which requires nucleolar ribosomal functions. Ribosome biogenesis consumes a large proportion of the cell's resources and energy, and so is tightly regulated through an intricate signaling network to guarantee fidelity. Thus, events that impair ribosome biogenesis cause nucleolar stress. In response to this stress, several nucleolar ribosomal proteins (RPs) translocate to the nucleoplasm and bind to MDM2. MDM2-mediated ubiquitination and degradation of the tumor suppressor p53 is then blocked, resulting in p53 accumulation and the induction of p53-dependent cell cycle arrest and apoptosis. Nucleolar stress is therefore a quality control surveillance mechanism that monitors the synthesis and assembly of the rRNA and protein components of ribosomes. Although nucleolar stress signaling pathways have been extensively analyzed, critical questions remain about their regulatory mechanisms. For example, how do RPs translocate from the nucleolus to the nucleoplasm to exert their functions, and do these p53-regulating RPs influence the prognosis of human cancer patients? Our laboratory recently identified the nucleolar protein PICT1 as a novel regulator of nucleolar stress. PICT1 sequesters the ribosomal protein RPL11 in the nucleolus, preventing it from binding to MDM2. MDM2 is then free to degrade p53, favoring tumor cell growth. Accordingly, the level of PICT1 in a tumor is becoming a useful prognostic marker for human cancers. This review summarizes the evidence that links nucleolar stress to tumorigenesis, and casts PICT1 as an oncogenic player in human cancer biology.
细胞生长需要新的蛋白质合成,这需要核仁核糖体的功能。核糖体生物发生消耗了细胞的大量资源和能量,因此通过复杂的信号网络进行严格调节,以保证保真度。因此,损害核糖体生物发生的事件会导致核仁应激。作为对此应激的响应,一些核仁核糖体蛋白(RPs)易位到核质并与 MDM2 结合。然后,MDM2 介导的肿瘤抑制因子 p53 的泛素化和降解被阻断,导致 p53 积累并诱导 p53 依赖性细胞周期停滞和细胞凋亡。因此,核仁应激是一种质量控制监测机制,可监测 rRNA 和核糖体蛋白成分的合成和组装。尽管已经广泛分析了核仁应激信号通路,但关于其调节机制仍存在关键问题。例如,RPs 如何从核仁易位到核质以发挥其功能,以及这些调节 p53 的 RPs 是否会影响人类癌症患者的预后?我们的实验室最近确定核仁蛋白 PICT1 是核仁应激的一种新型调节因子。PICT1 将核糖体蛋白 RPL11 隔离在核仁中,防止其与 MDM2 结合。然后,MDM2 可以自由降解 p53,有利于肿瘤细胞生长。因此,肿瘤中的 PICT1 水平正在成为人类癌症的一种有用的预后标志物。这篇综述总结了将核仁应激与肿瘤发生联系起来的证据,并将 PICT1 视为人类癌症生物学中的致癌因子。